Feed aggregator

ChrisHartman: Huber Needles: Recall - Risk of Coring http://bit.ly/at01pn

Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient’s lungs.

ChrisHartman: Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens http://bit.ly/9noeFa

Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices.

This page is the text of all the cases associated with Lessons 1 and 2 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events.”

This three-day intensive program is designed to help primary care practices, networks, and systems sift through the myriad regulations, measurements, models, and demands to hone an essential set of skills and craft an organization-specific sequenced plan for primary care redesign that meets the needs of participating organizations and their communities.

This transcript is the text of all videos associated with Lesson 4 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events.”

ChrisHartman: TimeOut Capsules: Undeclared Drug Ingredient http://bit.ly/aD9JZp

During a 10-day trip to the north of Ghana, the IHI Project Fives Alive! team gathered stories and shared notes on the work of the sites they visited in Upper West, Upper East, and Northern Regions.

Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

This transcript is the text of all videos associated with Lesson 3 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events."

This transcript is the text of all videos associated with Lesson 2 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events.”

ChrisHartman: MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient http://bit.ly/9IhLom

UPDATED 08/25/2010. Product marketed as dietary supplement contains undeclared Aminotadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

ChrisHartman: Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation: Recall - Risk of Thromboembolic Events http://bit.ly/cyA1x3

Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.

ChrisHartman: Mr. Magic Male Enhancer: Undeclared Drug Ingredient http://bit.ly/9ii2RU

Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil and sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

ChrisHartman: INOMAX DS Drug-Delivery System: Class I Recall - Risk of Interruption of Drug Flow http://bit.ly/dAqe7c

Potential for failure of a pressure switch, which may have an impact on the administration of INOMAX for inhalation to patients.